好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Epilepsy Therapy

Thursday 04/17/08
07:00 PM - 09:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Therapy Program
Susan T. Herman, MD, FAAN
Participants should become familiar with the epidemiology of seizures following acute brain injuries; strategies for prophylaxis and/or treatment of acute symptomatic seizures; risk of development of epilepsy after brain tumor, traumatic brain injury, and stroke; treatment of remote symptomatic epilepsy, including antiepileptic drug therapy and surgery; avoidance of side effects and drug interactions in patients with neurologic comorbidities; and discontinuation of antiepileptic drug therapy in patients with remote symptomatic epilepsy.
No CME available
Patient Care & Procedural Skills, Medical Knowledge
Advanced
Practitioner, Fellow, Academician, Resident, Nurse
Event Timeline
07:00 PM - 07:35 PM Seizures in Patients with Brain Tumors
Joseph I. Sirven, MD, FAAN
07:00 PM - 09:00 PM Reception
07:35 PM - 08:10 PM Seizures and Epilepsy After Traumatic Brain Injury
Ramon R. Diaz-Arrastia, MD, PhD, FAAN
08:10 PM - 08:45 PM Post-stroke Seizures and Epilepsy
Susan T. Herman, MD, FAAN
08:45 PM - 09:00 PM Questions and Answers
Faculty Disclosures
Joseph I. Sirven, MD, FAAN Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration .
Susan T. Herman, MD, FAAN The institution of Dr. Herman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioserenity. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for National Association of Epilepsy Centers. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. Dr. Herman has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. The institution of Dr. Herman has received research support from Epilepsy Foundation; Epilepsy Learning Healthcare System. The institution of Dr. Herman has received research support from CREMedical. The institution of Dr. Herman has received research support from NIH/NINDS. The institution of Dr. Herman has received research support from Marinus. The institution of Dr. Herman has received research support from Neuroelectrics, Inc. Dr. Herman has received personal compensation in the range of $500-$4,999 for serving as a Medical Director, Neurodiagnostics Program with Laboure College. Dr. Herman has a non-compensated relationship as a Professional Advisory Board member with Epilepsy Foundation that is relevant to AAN interests or activities.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.